Future vaccines for HIV.

Future vaccines for HIV.

Detalles Bibliográficos
Main Authors:	Blanchard, T, Rowland-Jones, S, Gotch, F, McMichael, A, Smith, G
Formato:	Journal article
Idioma:	English
Publicado:	1996

Títulos similares

Cytotoxic T lymphocytes in HIV infection
por: Rowland-Jones, S, et al.
Publicado: (1993)

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.
por: Rowland-Jones, S, et al.
Publicado: (1993)

Immune responses in HIV-exposed seronegatives: have they repelled the virus?
por: Rowland-Jones, S, et al.
Publicado: (1995)

Recognition of viral antigens at the cell surface.
por: McMichael, A, et al.
Publicado: (1995)

Anti-HIV cellular immunity: recent advances towards vaccine design.
por: Goulder, P, et al.
Publicado: (1999)

The dynamics of the cellular immune response to HIV infection: implications for vaccination.
por: Mcmichael, A, et al.
Publicado: (2000)

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
por: Rowland-Jones, S, et al.
Publicado: (1995)

Role of cellular immunity in protection against HIV infection.
por: Rowland-Jones, S, et al.
Publicado: (1997)

Cellular immune responses to HIV.
por: Mcmichael, A, et al.
Publicado: (2001)

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime.
por: Hanke, T, et al.
Publicado: (1999)

HIV: Bad news for stop--start therapy?
por: Mcmichael, A, et al.
Publicado: (2002)

Design and tests of an HIV vaccine.
por: McMichael, A, et al.
Publicado: (2002)

HIV: vaccines out of Africa.
por: Rowland-Jones, S
Publicado: (2001)

HIV vaccines.
por: Mcmichael, A
Publicado: (2006)

HIV T cell vaccines, the importance of clades.
por: McMichael, A, et al.
Publicado: (2002)

HIV-1 vaccines: let's get physical.
por: Goonetilleke, N, et al.
Publicado: (2013)

Comment on clinical development of candidate HIV vaccines: different problems for different vaccines.
por: McMichael, A, et al.
Publicado: (2014)

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
por: Rowland-Jones, S, et al.
Publicado: (1995)

A winding road towards an HIV vaccine.
por: Rowland-Jones, S
Publicado: (2008)

HIV escapes from cytoxic lymphocytes
por: McMichael, A, et al.
Publicado: (1996)

pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART
por: Ondondo, B, et al.
Publicado: (2005)

Is an HIV vaccine possible?
por: Mcmichael, A, et al.
Publicado: (1999)

New templates for HIV-1 antibody-based vaccine design.
por: Sattentau, Q, et al.
Publicado: (2010)

Escape from immune control by HIV
por: McMichael, A, et al.
Publicado: (1997)

The human cytotoxic T cell response to influenza A vaccination.
por: Mcmichael, A, et al.
Publicado: (1981)

The role of cytotoxic T-cells in HIV infection.
por: Rowland-Jones, S, et al.
Publicado: (1998)

Unusual antigen presentation offers new insight into HIV vaccine design
por: McMichael, A, et al.
Publicado: (2017)

HIV vaccines 1983-2003.
por: Mcmichael, A, et al.
Publicado: (2003)

Recognition of influenza A virus by human cytotoxic T lymphocytes.
por: Mcmichael, A, et al.
Publicado: (1989)

High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals.
por: Gotch, F, et al.
Publicado: (1990)

Lessons from the failure of the adenovector HIV vaccine.
por: Blais, M, et al.
Publicado: (2009)

Is a human CD8 T-cell vaccine possible, and if so, what would it take? Could a CD8+ T-cell vaccine prevent persistent HIV infection?
por: McMichael, A
Publicado: (2017)

Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
por: Bodmer, H, et al.
Publicado: (1989)

The importance of cellular immune response to HIV: implications for antibody production and vaccine design
por: Brenna, E, et al.
Publicado: (2021)

A review of vaccines for HIV prevention.
por: Mwau, M, et al.
Publicado: (2003)

In pursuit of an HIV vaccine: an interview with Andrew McMichael.
por: Mcmichael, A
Publicado: (2013)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
por: Dorrell, L, et al.
Publicado: (2000)

A human lymphocyte-associated antigen involved in cell-mediated lympholysis.
por: Hildreth, J, et al.
Publicado: (1983)

An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope.
por: Nixon, D, et al.
Publicado: (1990)

HIV-host interactions: implications for vaccine design
por: Haynes, B, et al.
Publicado: (2016)